About
About CTSNet
Leadership
Participation
Sponsors
Industry Resources
Disclaimer
Policies
Contact Us
Journals
Journals
JANS
Books
For Authors
Submit Content
Submit Event
Submission Guidelines
Innovation Video Competition
CTSNet Resident Video Competition
Log In
Submit Content
Home
Learning Hub
Cardiac
Allied Health
Learning Hub
Jobs
U.S. Career Center
European Career Center
Events
Upcoming Events
Calendar View
Abstract Deadlines
Submit Event
Profiles
CTSNET Global
About
About CTSNet
Leadership
Participation
Sponsors
Industry Resources
Disclaimer
Policies
Contact Us
Journals
Journals
JANS
Books
For Authors
Submit Content
Submit Event
Submission Guidelines
Connecting the global cardiothoracic community
Sponsored in Part By
Home
Learning Hub
Cardiac
Thoracic
Congenital
Guest Editor Series
Roundtables and Webinars
Surgeon Spotlights
Meeting Presentations
For Residents
Allied Health
COVID-19
The Beat
CTSNet To Go
Jobs
U.S. Career Center
European Career Center
Events
Upcoming Events
Calendar View
Abstract Deadlines
Submit Event
Profiles
CTSNET Global
Sponsored
Lung Cancer - Molecular Markers
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
By
Aristotle Protopapas
Nov. 10, 2023
0
Cancer
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
By
Aristotle Protopapas
May. 26, 2022
0
Cancer
Lung Cancer in France
By
Aristotle Protopapas
Jan. 27, 2021
0
Cancer
Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer
By
Aristotle Protopapas
Nov. 21, 2020
0
Lung
Year in Review: Lung Cancer
By
Mark Ferguson
Nov. 7, 2019
0
Arrhythmias
In Global News: Cardiac Regeneration in Pigs, Health Effects of Marijuana Use, and Running to Reduce Aortic Stiffness
By
Claire Vernon
May. 10, 2019
0
Thoracic
Nivolumab Plus Ipilimumab in Lung Cancer With a High Tumor Mutational Burden
By
Mark Ferguson
Jun. 1, 2018
0
Thoracic
Pembrolizumab Plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
By
Mark Ferguson
May. 31, 2018
0
Thoracic
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
By
Mark Ferguson
May. 24, 2018
0
Thoracic
Lung Cancer: Blood-based Biomarker Predicts Immunotherapy Success
By
Mark Ferguson
Dec. 13, 2017
0
Thoracic
Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters
By
Mark Ferguson
Oct. 31, 2017
0
Thoracic
Lung Cancer Awareness Month—A Lot of Progress, But More Work Needs to Be Done
By
Mark Ferguson
Oct. 24, 2017
0
1
2
3
Log In
New to CTSNet?
Sign Up
Email
Password
Remember me
Log In
Forgot Password